￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Long-term VIVID-2 data for militizumab in Crohn's disease

2026-02-01 22:25:32

Check Details
Which country specifically produces selumetinib?

2026-02-01 22:25:32

Check Details
Basic information and pharmacological effects of cabozantinib

2026-02-01 22:25:32

Check Details
Whether lorlatinib/lorlatinib targeted drug is included in medical insurance and its price

2026-02-01 22:25:32

Check Details
Upadatinib shows promise in treating refractory Crohn's disease

2026-02-01 22:25:32

Check Details
The correct dosage and method of taking nintedanib

2026-02-01 22:25:32

Check Details
Canafenib/bimetinib sets a precedent for improved treatment of BRAF V600E-mutated non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Teritusumab efficacy after prior BCMA-guided therapy in RR multiple myeloma

2026-02-01 22:25:32

Check Details
In the Phase 3 QuANTUM-Wild Trial of Quizartinib in Newly Diagnosed FLT3-ITD-Negative Acute Myeloid Leukemia

2026-02-01 22:25:32

Check Details
Pomalidomide shows promise in boosting immune response in myeloma

2026-02-01 22:25:32

Check Details
What is the medical insurance reimbursement rate for lapatinib and what are the restrictions?

2026-02-01 22:25:32

Check Details
What are the main functions and effects of filgotinib?

2026-02-01 22:25:32

Check Details
Category
相关知识